Comparison 4. Ephedrine versus placebo (stuttering priapism).

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Immediate side effects (palpitations) (after 6 months of treatment)	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
1.1 Ephedrine 15 mg	1		Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
1.2 Ephedrine 30 mg	1		Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
2 Immediate side effects (tachycardia) (after 6 months of treatment)	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
2.1 Ephedrine 15 mg	1		Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
2.2 Ephedrine 30 mg	1		Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
3 Immediate side effects (lack of sleep)	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
3.1 Ephedrine 15 mg	1		Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
3.2 Ephedrine 30 mg	1		Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
4 Immediate side effects (hand shaking)	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
4.1 Ephedrine 15 mg	1		Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
4.2 Ephedrine 30 mg	1		Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
5 Immediate side effects (anxiety) (after 6 months of treatment)	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
5.1 Ephedrine 15 mg	1		Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
5.2 Ephedrine 30 mg	1		Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
6 Immediate side effects (dry mouth) (after 6 months of treatment)	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
6.1 Ephedrine 15 mg	1		Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
6.2 Ephedrine 30 mg	1		Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]